申请人:AstraZeneca AB
公开号:US08889671B2
公开(公告)日:2014-11-18
Compounds of formula (I), pharmaceutically acceptable salts thereof, and uses of the compounds of formula (I) for treating bacterial infections are disclosed.
公开了式(I)的化合物,其药学上可接受的盐,以及使用式(I)的化合物治疗细菌感染的用途。